FDA Announces Safety Warning For Users Of Samsca
May 7, 2013
The U.S. Food and Drug Administration (FDA) recently made an announcement regarding the safety of the drug Samsca. The statement explained that taking the medication for extended periods of time could result in a serious Drug Injury.
Samsca is a medication used in the treatment of a condition known as hyponatremia, in which a patient’s blood contains low levels of sodium. The medication is manufactured by Otsuka American Pharmaceutical, Inc. and has been on the market since May of 2009.
The problem with the medication was discovered while the company was preforming clinical trials on a new use of the drug in treating patients with autosomal dominant polycystic kidney disease (ADPKD). During testing, researchers discovered that extended use of the medication could lead to serious liver damage.
In response to the discovery, the company has stated patients should not take the medication for longer than 30 days at a time. Patients who suffer from liver damage, such as cirrhosis of the liver, should not take the drug either. Doctors have been instructed to closely monitor patients for such liver damage if the drug is prescribed.
Ferrer, Poirot & Wansbrough and their team of Dallas Personal Injury Attorneys acknowledge how devastating an injury caused by taking a medication can be. The firm may be able to help a person who has suffered negative affects of taking a medication prescribed by a doctor.